Hair transplant and HIV: viral load, medication and safe care

What matters more than HIV status

HIV is not, in itself, a reason to refuse surgery. The perioperative guideline from the New York State Department of Health AIDS Institute, updated in 2024, states this among its aims and notes that caring for an adult with HIV around an operation is largely the same as caring for any adult. For someone on treatment whose viral load is below 200 copies/mL and whose CD4 count is above 200 cells/mm³, it advises going ahead with the surgical plan as for a patient without HIV.

The NHS explains that, with treatment, most people with HIV can live a long and healthy life, and that people on effective treatment with an undetectable viral load cannot pass the virus on. HIV then becomes a long-term condition under regular review, and the assessment centres on overall health far more than on the diagnosis itself.

Any other health conditions are reviewed under the rules that apply to every candidate: coexisting hepatitis B or C, diabetes or heart disease all feed into the decision, alongside the quality of the donor area. These general criteria are the subject of our guide to hair transplant contraindications.

Some people keep a low CD4 count despite years of undetectable viral load, because their immune system has only partly recovered. The New York guideline points out that postponing surgery is unlikely to raise that figure, so the decision is made with the HIV clinician, based on overall clinical stability.

Viral load and CD4 count: reading your results before you ask for a quote

The viral load measures how much virus is present in the blood. It is described as undetectable once it falls below the level the laboratory can measure, a sign that treatment is working. The CD4 count reflects the strength of the immune defences, and a higher count means the body is better able to fight off infection.

Before planned surgery, the same guideline asks for a viral load result from the past 6 months and a CD4 count from the past 12 months. Where the viral load is undetectable, the lack of a recent CD4 count should not hold up the operation. A viral load of 200 copies/mL or more, or a CD4 count of 200 cells/mm³ or less, is a reason to consult the HIV clinician before a date is set.

The table below summarises the usual next step for each situation, with the final decision resting with the surgeon.

Your latest results	Usual next step
Viral load < 200, CD4 > 200	Usual pathway
Viral load ≥ 200 copies/mL	HIV clinician’s advice first
CD4 ≤ 200 cells/mm³	HIV clinician’s advice first
Not yet on treatment	Start treatment first
Long-standing low CD4, undetectable	Decision with your clinician

When treatment needs to be started or changed, the guideline recommends discussing the pros and cons of waiting with the patient. A hair transplant is a planned procedure that can wait a few months without harm to health, until a new blood test confirms that the virus is under control.

If this applies to you, prepare your enquiry with your latest viral load and CD4 results and their dates, the exact name and dose of your treatment, a list of your other medicines and, where relevant, your hepatitis B or C results.

Infection control in theatre: why the same rules apply to everyone

The WHO describes standard precautions as the minimum level of infection control to be used in the care of all patients, to reduce the spread of bloodborne and other pathogens from both recognised and unrecognised sources. They cover hand hygiene, gloves and face protection, careful handling of needles and blades, safe disposal of clinical waste and reprocessing of reusable equipment before it is used for another patient.

The NHS notes that many people with HIV do not know they have it, which is precisely why these rules are applied to everyone in exactly the same way. Disclosing an HIV diagnosis therefore changes nothing about theatre hygiene, but it does protect the patient, because it allows their medicines to be checked for interactions.

For the surgical team, the New York guideline describes the risk of HIV transmission during an operation as extremely low. In the United States, two surgical technicians and no surgeons reported an occupational infection to the CDC, the federal public health agency, between 1985 and 1999, with none reported since. Where the patient’s viral load is suppressed by treatment, the guideline regards this risk as eliminated.

Some clinics advertise a separate operating room for HIV-positive patients or a special sterilisation process. Neither appears in the guidance cited here, which sets out universal surgical precautions against blood exposure for every patient. The same measures also protect you from infections carried by instruments, and you are welcome to ask our team how instruments are sterilised and which items are single-use, as with any other question about whether a hair transplant in Turkey is safe.

What the evidence on surgery and HIV shows

The available data come from operations that are more major than a hair transplant and carried out in hospital, such as appendix removal, hip replacement, and bowel or heart surgery. We have found no published study looking specifically at hair transplants in people living with HIV, so this research offers general reference points.

A study at Kaiser Permanente in Northern California compared 332 HIV-positive patients operated on between 1997 and 2002 with the same number of HIV-negative patients matched for age, sex and type of procedure. Complications were equally common in both groups (11.1% versus 10.2%), apart from pneumonia, although the HIV-positive patients had more deaths over the following year. A viral load of 30,000 copies/mL or more was linked to more complications, with an adjusted odds ratio of 2.95, whereas a CD4 count below 200 cells/mm³ was not.

A meta-analysis published in the Journal of Medical Virology in 2025 pooled 50 studies covering 54,565 people living with HIV. Compared with HIV-negative patients, it found more complications, with an odds ratio of 1.56, along with higher mortality and reoperation rates and longer hospital stays. Analysis by specialty found this excess of complications in orthopaedic and general surgery. CD4 count did not explain the differences in complications, whereas the proportion of patients on antiretroviral treatment accounted for nearly 35% of the variation between studies, and the authors call for prospective research to confirm the findings.

For its part, the New York guideline concludes that in people whose HIV is controlled and whose CD4 count is higher, the risk of complications and death after surgery is about the same as in people without HIV. Effective treatment that keeps your viral load low is therefore the factor within your control. A hair transplant is done under local anaesthetic as a day case, on superficial wounds in the scalp, which sets it apart from the operations studied.

The choice between FUE and DHI follows the usual criteria, such as the size of the area to cover and the density of the donor area, and HIV status does not dictate a particular technique. Our complete hair transplant guide walks through each stage, from harvesting the grafts to placing them.

Antiretrovirals and surgical medicines: the interactions to check

Antiretroviral treatment continues without a break before, during and after the transplant. The New York authors ask for any interruption around surgery to be avoided and warn that stopping treatment can trigger a hepatitis flare in someone who also has hepatitis B. For long-acting injectable treatment, the transplant date is planned around the injection schedule so that no dose is missed.

Some antiretrovirals change the way the body clears other medicines, through enzymes known as cytochrome P450. Protease inhibitors, non-nucleoside reverse transcriptase inhibitors and regimens “boosted” with ritonavir or cobicistat are the ones most often involved.

Two medicines linked to the procedure deserve particular attention. For lidocaine, a widely used local anaesthetic, the guideline’s interaction table notes that blood levels may rise with regimens boosted with ritonavir or cobicistat and states that the two should not be given together, whereas no interaction is expected with bictegravir, cabotegravir, dolutegravir or raltegravir. If sedation is being considered, midazolam raises a similar issue: the oral form is contraindicated with these boosted regimens, and the injectable form is used only with appropriate monitoring, because of the risk of prolonged sedation or respiratory depression.

Steroids call for the same caution. The guideline highlights a higher risk of adrenal insufficiency in people who have lived with HIV for many years, have a low CD4 count, or have taken both a boosted regimen and glucocorticoids. It also flags a possible interaction between non-steroidal anti-inflammatory drugs, such as ibuprofen, and tenofovir disoproxil, which is found in several HIV treatments.

You are not expected to know these interactions in detail, and you should never change any medicine on your own. Ask your HIV clinician for a letter setting out your treatment and doses, together with any precautions for local anaesthetics, sedatives, steroids, antibiotics and painkillers. Where an interaction cannot be avoided, the guideline calls for an experienced HIV clinician to be consulted before surgery to plan how medicines are managed. The medical team then chooses the medicines with full knowledge of your treatment, following the principles described in our article on hair transplant anaesthesia.

Testing, confidentiality and PrEP: particular situations

The blood tests carried out at the clinic before the transplant include infection screening, covering hepatitis B and C and HIV. If you know you are HIV positive, mention it at your first contact and send your results, so the team can review your treatment in advance and the screening on the day holds no surprises. Your status remains medical information, intended for the team caring for you.

If you have never had a test, or your last one was some months ago, have one before you travel. In the UK, a GP or sexual health clinic can offer an HIV test, and home testing kits are available from pharmacies or can be ordered online, with free kits for those who are eligible. Choose a home kit that is clearly marked for self-testing and carries a CE mark.

A positive result always needs a second blood test at a clinic, followed by referral to specialist HIV care. Learning about a diagnosis at the start of a trip abroad, far from your own doctor and the people close to you, is a strain you can spare yourself, especially as a new diagnosis puts starting treatment ahead of any planned procedure.

PrEP, or pre-exposure prophylaxis, is taken by HIV-negative people to reduce their risk of getting HIV. If you take it, include it in your list of medicines: PrEP tablets contain tenofovir disoproxil, which calls for the caution with anti-inflammatories mentioned above. The regular tests that come with your PrEP care also give you a recent result to share.

Can HIV treatment cause hair loss?

Some antiretrovirals have been linked to hair loss. A review published in Annals of Pharmacotherapy in 2014 gathered 46 cases from 17 publications: protease inhibitors, indinavir in particular, were most often involved, followed by lamivudine. The hair loss mainly affected the scalp and appeared a median of 2.5 months after the medicine was started.

Stopping or replacing the suspected medicine led to at least partial regrowth in half the cases, and the authors expect regrowth within 1 to 3 months. They stress the need to look for other causes, considering the pattern of hair loss, medical history, other medicines and family history of baldness. A deficiency, a thyroid disorder or alopecia areata is looked for in the same way.

Hair loss that begins after a change of treatment should therefore be discussed with your HIV clinician before any transplant is planned, since it may reverse. A transplant is suited to diagnosed androgenetic alopecia, when the band of hair at the back and sides of the head holds enough follicles to harvest for the result you are hoping for.

After the procedure: healing, staying mobile and warning signs

When HIV is under control, recovery follows the same course as for other patients: small scabs, temporary redness, then a temporary shedding of the transplanted hairs before the gradual regrowth set out in our hair transplant timeline. Keep taking your antiretrovirals at your usual times, including on the day of the procedure and the day you fly home.

If a fever develops after surgery, the New York guideline advises considering the causes common to all surgical patients first, such as a wound or urinary infection, before those related to HIV. When the CD4 count is 200 cells/mm³ or less, it also recommends seeking advice from an infectious diseases specialist.

Contact the team promptly if redness spreads around the grafts, pain increases after the first few days, cloudy fluid leaks from the area or you develop a fever, and send a clear photo of your scalp. Let your HIV clinician know too, and do not take antibiotics without medical advice, as our article on infection after a hair transplant explains.

The same guideline notes a higher risk of venous thrombosis in people living with HIV and stresses getting back on your feet quickly after surgery. Get up as soon as the team allows, drink regularly and move your legs during the journey home, following our advice on flying after a hair transplant.

Planning your hair transplant in Istanbul with Body Expert

Your enquiry starts with photos of your scalp and your medical details, including the name of your treatment and the date of your most recent results. Our team replies with a free quote within 24 hours, with no obligation. Before settling on a date, the surgeon may want to see your clinician’s letter or a more recent blood test.

During your stay, your English-speaking patient coordinator remains your point of contact from arrival to departure. VIP transfers take you from the airport to your 5-star hotel and on to the clinic, and breakfast is served at the hotel each morning. Tell the medical team when you take your doses, so that they can allow for them when planning the day of surgery.

Pack enough antiretrovirals for the whole stay, plus a few days’ reserve in case a flight is delayed, and keep them in your hand luggage in their original packaging, together with your prescription. Istanbul is two hours ahead of the UK in summer and three in winter, and your HIV clinician can advise on timing your doses to keep a regular interval. To see where these steps fall in your trip, look at the outline of a hair transplant in Istanbul, day by day.

Back home, you stay in touch with our team, sending photos as you go, throughout the 12-month post-operative follow-up, carried out remotely. Meanwhile, your HIV care carries on with your usual clinic: give them the list of medicines you received in Istanbul, so they can check these are compatible with your treatment.

Sources

Horberg, M. A., Hurley, L. B., Klein, D. B., Follansbee, S. E., Quesenberry, C., Flamm, J. A., Green, G. M., & Luu, T. (2006). Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Archives of Surgery, 141(12), 1238-1245. https://doi.org/10.1001/archsurg.141.12.1238

Li, K., Luo, L., Ji, Y., & Zhang, Q. (2025). Urgent focus on the surgical risks of people living with HIV: A systematic review and meta-analysis. Journal of Medical Virology, 97(2), e70260. https://doi.org/10.1002/jmv.70260

NHS. (2025). HIV and AIDS. https://www.nhs.uk/conditions/hiv-and-aids/

Shin, S. J., Vail, R. M., Shah, S. S., Fine, S. M., McGowan, J. P., Merrick, S. T., Radix, A. E., Rodrigues, J., Hoffmann, C. J., Norton, B. L., & Gonzalez, C. J. (2024). Perioperative care in adults with HIV. New York State Department of Health AIDS Institute; Johns Hopkins University. https://www.ncbi.nlm.nih.gov/books/NBK576018/

Woods, E. A., & Foisy, M. M. (2014). Antiretroviral-related alopecia in HIV-infected patients. Annals of Pharmacotherapy, 48(9), 1187-1193. https://doi.org/10.1177/1060028014540451

World Health Organization. (2007). Standard precautions in health care [Aide-memoire]. https://cdn.who.int/media/docs/default-source/documents/health-topics/standard-precautions-in-health-care.pdf